Abstract
Objective. Previous studies have examined the association between breastfeeding and rheumatoid arthritis (RA), but their results were inconsistent. The aim of this study was to perform a metaanalysis to clarify the effect of breastfeeding on RA risk.
Methods. The PubMed, EMBASE, Chinese National Knowledge Infrastructure, and Wanfang databases were searched for relevant studies published up to September 10, 2014. Data were extracted, and multivariable-adjusted OR with 95% CI were pooled in the random-effects model.
Results. A total of 6 studies were included in the metaanalysis (RA cases: 1672, sample size: 143,670). Overall, an inverse association between breastfeeding and RA was observed (OR 0.675, 95% CI 0.493–0.924, p = 0.014). In the subgroup analysis, decreased RA risk was also found in both breastfeeding 1–12 months (OR 0.783, 95% CI 0.641–0.957, p = 0.015) and breastfeeding > 12 months (OR 0.579, 95% CI 0.462–0.726, p < 0.0005). Sensitivity analysis and cumulative analysis further strengthened the validity of the results. No publication bias was found in this metaanalysis.
Conclusion. This metaanalysis suggests that breastfeeding is associated with a lower risk of RA, no matter if breastfeeding time is longer or shorter than 12 months.
Rheumatoid arthritis (RA) is the most common autoimmune inflammatory joint disease worldwide, affecting about 0.5% to 1% of the adult population1. RA, which is characterized by erosive symmetrical polyarthritis, can lead to joint destruction, disability, and a poor quality of life if not appropriately treated2. The prevalence of RA increases with age, and women are more susceptible to RA than men3. Although the etiology of RA remains elusive, epidemiological studies have suggested that hormonal factors are important in the development of RA4,5.
Breastfeeding, a common practice for adult women with newborns, is known to have multiple health benefits for the baby and may protect mothers against breast cancer and ovarian cancer6,7,8,9. Amelioration of RA has been observed during pregnancy with exacerbation in the postpartum period10, and breastfeeding might play an important role in this apparent paradoxical result. The influence of breastfeeding on the risk of developing RA has been investigated in a number of studies, but their results were inconsistent, with increased risk, reduced risk, or no discernable effect reported11,12,13,14,15,16,17,18,19.
Given a single study may lack the power to provide a reliable conclusion, metaanalysis is often used to enhance statistical power, and thus is likely to produce a more convincing conclusion. To our knowledge, there has been no metaanalysis investigating the association between breastfeeding and RA risk to date. Therefore, we performed quantitative metaanalyses to derive a more precise estimation of the relationship between them.
MATERIALS AND METHODS
Publication search
Observational studies (case-control, nested case-control, and cohort studies) on breastfeeding and RA development were included in our metaanalysis, irrespective of language or publication status and article type. Two investigators (Chen and Zhou) conducted a comprehensive, computerized literature search through the PubMed, EMBASE, Chinese National Knowledge Infrastructure (CNKI), and Wanfang databases up to September 10, 2014. The following search terms were used: “rheumatoid arthritis” or “RA” and “breastfeeding” or “breast feeding.” We also perused the reference lists of selected research papers and reviews to identify additional relevant studies.
Inclusion and exclusion criteria
Two authors (Chen and Wang) independently evaluated all of the studies retrieved based on the prespecified selection criteria. Eligible studies met the following inclusion criteria: (1) any type of observational study investigating the relationship between breastfeeding and RA development, (2) reported the relative risk (RR) or and its 95% CI for the association between breastfeeding and RA development, and (3) included patients diagnosed with RA based on the American College of Rheumatology criteria for RA. Studies were excluded if any of the following existed: (1) not relevant to breastfeeding or RA risk; (2) did not contain adequate data for inclusion; (3) included duplicate data; (4) was about juvenile RA; (5) was not in English; (6) was an editorial, review, or abstract; and (7) had unadjusted data. If more than 1 study used the same cases, the 1 with the most comprehensive population was included.
Data extraction
Three investigators (Chen, Wang, and Yin) independently extracted data from the included studies. The following information was collected from each study: first author’s name, year of publication, original country, ethnicity, age group, sample size, and subgroup information. We verified the accuracy of the data by comparing collection forms between investigators. If different results were generated, the full text of the article was checked.
Statistical analysis
The strength of the associations between breastfeeding and RA risk was measured by OR and 95% CI. The random-effects model was used. The statistical significance of summary OR was determined with the Z test. Heterogeneity was assessed by the I2 statistic. We considered low, moderate, and high I2 values to be 25%, 50%, and 75%, respectively. A chi-square–based Q test was also performed to check the between-study heterogeneity. To explore the main source of heterogeneity, subgroup analyses were performed by breastfeeding time. To assess the stability of the metaanalysis, 1-way sensitivity analyses were carried out. Funnel plot was used to assess potential publication bias. The Egger test was used to quantitatively assess publication bias. All statistical tests were performed using STATA 12.0 software (Stata Corp.). A p value of < 0.05 was considered significant.
RESULTS
Study characteristics
The result of the study selection process is shown in Figure 1. The initial search produced 169 studies from the PubMed, EMBASE, CNKI, and Wanfang databases. After exclusion of duplicates, 72 potentially eligible studies were selected. After detailed evaluations, 10 studies were full-text reviewed and 4 studies were excluded (3 studies used duplicate data17,18,19 and 1 had no relation to RA onset, but with severity of RA20). Finally, in the current study, 6 eligible studies11,12,13,14,15,16 that met the inclusion criteria were included in our metaanalysis. There were 5 studies on whites and 1 study on Asians. There were 3 case-control studies containing 241 RA cases and 859 controls, and 3 cohort studies containing 1431 RA cases from 142,570 participants. Four studies had subgroup analysis on breastfeeding time, and 3 of them could be selected into our subgroup analysis. The characteristics of each study included in this metaanalysis are shown in Table 1.
Flow of study identification, inclusion, and exclusion. RA: rheumatoid arthritis.
General characteristics of the included studies of breastfeeding and risk of RA.
Quantitative synthesis
All of the main results of the metaanalysis are shown in Table 2. Overall, an inverse association between breastfeeding and RA risk was found (breastfeeding ever vs never: OR 0.675, 95% CI 0.493–0.924; Figure 2). Next, we performed an analysis on data stratified by breastfeeding time and ethnicity with the attempt to search for possible factors that might affect the results. In the subgroup analysis of breastfeeding time, protective effect of breastfeeding on RA development was also found in breastfeeding 1–12 months (breastfeeding 1–12 vs never: OR 0.783, 95% CI 0.641–0.957) and breastfeeding > 12 months (breastfeeding > 12 vs never: OR 0.579, 95% CI 0.462–0.726). In the subgroup analysis by ethnicity, no significant associations were found among whites (OR 0.741, 95% CI 0.533–1.030, p = 0.074).
Metaanalysis of the association between breastfeeding and RA risk. A. Metaanalysis of breastfeeding on RA risk. B. Metaanalysis of breastfeeding on RA risk in whites. C. Metaanalysis of the association between breastfeeding 1–12 months and RA risk. D. Metaanalysis of the association between breastfeeding > 12 months and RA risk. RA: rheumatoid arthritis.
Results of metaanalysis for breastfeeding and RA risk.
Heterogeneity analysis
Significant heterogeneity existed in 1 model (breastfeeding ever vs never: p = 0.023, I2 = 61.2%). No heterogeneity existed in the other 3 models (breastfeeding for whites, ever vs never: p = 0.062, I2 = 55.4%; breastfeeding 1–12 mos vs never: p = 0.664, I2 = 0%; breastfeeding > 12 mos vs never: p = 0.496, I2 = 0%). The random-effect models were used in all models.
Sensitivity analyses and publication bias
Sensitivity analyses were performed to assess whether each individual study can affect the final results by using the Begg test and Egger test. Neither the Begg test nor the Egger test provided any obvious evidence of publication bias (Table 2). The shapes of the funnel plots appeared to be symmetrical in all genetic models (Figure 3). These results showed that no individual study affected the final results in diverse genetic models using the exclusion method step by step.
Funnel plots for breastfeeding and RA risk. A. Effect of breastfeeding on general RA risk. B. Effect of breastfeeding on RA risk in whites. C. Effect of breastfeeding 1–12 months and RA risk. D. Effect of breastfeeding > 12 months and RA risk. RA: rheumatoid arthritis.
DISCUSSION
Our study incorporates the available published observational studies including 1672 patients with RA, and aims to provide a qualitative estimate of the association between breastfeeding and RA risk. A total of 6 studies were systematically evaluated, and an inverse association between breastfeeding and RA development was found in the overall study population. In the subgroup analysis of breastfeeding time, we found that both breastfeeding 1–12 months and breastfeeding > 12 months could significantly decrease the development of RA. In the subgroup analysis by ethnicity, no significant association between breastfeeding and RA risk was found in whites. Only 1 study investigated the association between breastfeeding and RA risk in Asians, and none of the articles were about Africans. Thus, more studies with Asians or Africans are still needed.
Breastfeeding is known to have multiple health benefits for the baby and may protect mothers against breast cancer and ovarian cancer6,7,8,9,21,22. A number of studies concerning the influence of breastfeeding on the risk of RA have yielded conflicting results11,12,13,14,15,16,17,18,19. Berglin, et al14 conducted a study restricted to patients with early RA who developed RA within 1 year and reported that breastfeeding increased the risk of developing RA. Possible explanations supporting the results of increased risk for RA with breastfeeding could be the high serum levels of prolactin during breastfeeding that have been shown to have immunostimulatory effects and could lead to the development of RA by several mechanisms23. In contrast, Karlson, et al and Pikwer, et al reported a significantly reduced risk of RA in women with longterm breastfeeding12,13. One proposed mechanism for this protective effect is through antiinflammatory progesterone, which rises during pregnancy and continues to be high during breastfeeding24. Another proposed mechanism is related to cortisol, which also has antiinflammatory effects and has been shown to be significantly higher among postmenopausal women who have breastfed25.
The antiinflammatory effects of pregnancy-related hormones and the short-term beneficial effects in RA are well known, but the longterm effects of pregnancy and the benefits of breastfeeding are less clear26. Our metaanalysis of the overall study suggested a protective effect of breastfeeding on RA risk. There were also controversies about the effect of breastfeeding time in the literature. Karlson, et al and Pikwer, et al considered a significant trend toward lower risk for RA with a longer duration of breastfeeding, especially those ≥ 13 months12,13. Jorgensen, et al found that the duration of breastfeeding had no influence on the risk of developing RA20. Our results suggested that both breastfeeding 1–12 months and breastfeeding > 12 months had a protective effect on RA development. Unfortunately, we could not make further comparison to determine which duration was better because of the lack of source data.
Results from this metaanalysis were stable and reliable. First, sensitivity analyses and cumulative metaanalyses revealed that the results were robust. Second, there was no significant heterogeneity in most of the comparisons. Third, the funnel plot and Egger tests found no significant publication bias. However, some limitations should be addressed. First, as a metaanalysis about observational studies, we could not resolve problems with confounding factors inherent in the included primary studies. Most of the included studies adjusted only for age and oral contraceptive use, and other important confounding factors were not standard, such as social class, smoking, genetic factors, parity, and alcohol consumption. Second, although there was no publication bias by the Begg funnel plot and Egger test, bias of selection may have occurred because only studies in English were selected.
To our knowledge, this was the first comprehensive metaanalysis to assess the relationship between breastfeeding and RA risk. This metaanalysis found that breastfeeding was moderately associated with a decreased risk of RA, no matter if the breastfeeding time was longer or shorter than 12 months.
Footnotes
Supported by the National Natural Science Foundation of China (81401355).
- Accepted for publication May 21, 2015.
REFERENCES
In this issue
